EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (Under Process) , 

 ISSN 2394-3211

Impact Factor: 4.897

 ICV - 79.57

Abstract

AN ASSOCIATIVE STUDY OF NON-LIPID RISK FACTORS (HIGH SENSITIVE-CRP, URIC ACID AND THYROID STIMULATING HORMONE) WITH PARAMETERS OF TYPE 2 DIABETES MELLITUS, BLOOD PRESSURE IN METABOLIC SYNDROME

V. Srinivasa Babu*, V. Kalyan Chakravarthy, C. Ramaswamy, S. Srikanth, M. Karthik

ABSTRACT

Background: Metabolic syndrome is the huddle of diseases for atherosclerotic cardiovascular disease (ASCVD) which arises due to excess of plasma glucose, cholesterol, fatty acids, blood pressure and obesity. The role of lipids in the development of MetS had been extensively studied. Some non-lipid factors like hsCRP, uric acid and TSH level also remain elevated in the serum of the MetS patients the correlation of the same with the MetS not fully determined. Aim and Objectives: Hence in this study our aim and objectives was to assess the significance of non-lipid risk factors in determining the severity of MetS with the association of type 2 diabetes and blood pressure parameters. Methods: A total of 450 subjects (211 men and 239 women) aged ≥ 35 years attending the hospital were divided based on the components of MetS as control (CS), Metabolic syndrome (MS) and severe (SMS) MetS groups. Comparative study was done by one way ANOVA and variables with significant associations were included in regression analysis to determine the future prediction with non-lipid risk factors hs-CRP, serum uric acid and TSH as dependent variables. The cardiovascular and T2DM related parameters FPG, HbA1c, serum fasting insulin, HOMA-IR, SBP, DBP, PR were independent variables in this study. Results: All the T2DM and BP variables had highly significant relation (P<0.001) when compared MetS and severe Mets group with control group. In this study, the value of participants HbA1C, PR, FPG, DBP and IR had significant Adjusted OR [3.03 P<0.001; 2.10 P 0.004; 1.86 P 0.033; 0.17, P <0.001 and 0.08, P <0.001 respectively] high positive correlation with the hs-CRP values. It was found that HbA1c, SBP, DBP, FPG and PR had significant predictive AOR [5.829 P<0.001; 2.789 P 0.007; 0.098 P<0.001; 0.383 P 0.008 and 0.543 P 0.053 respectively] in association with Uric acid values. Also, PR, FPG and DBP had significant AOR significance [1.96 P 0.001; 1.41 P <0.001; 1.37 P 0.026 respectively] in association with TSH values. Conclusion: It can be concluded that reducing the above T2DM and cardiovascular variables by various lifestyles or other means can reduce the levels of non-lipid risk factors and thereby arrest susceptibility of the development of MetS and severe MetS.

Keywords: T2DM; HTN; Metabolic syndrome; Non-lipid risks; hs-CRP; Uric acid; TSH.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 March 2019 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR MARCH ISSUE PUBLISHED

    MARCH 2019 Issue has been successfully launched on 1 March 2019

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from 4.161 to 4.897 due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (Under Process)